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INTRODUCTION
The PP2A holoenzyme is composed of one 
catalytic (C) subunit, one scaffold (A) subunit and one 
of many regulatory (B) subunits that provide substrate 
and subcellular localization specificity. PP2A-B subunit 
consists of four distinct subfamilies B55, B56, B” and 
B”’, with various isoforms for each subfamily [1, 2]. 
Different PP2A holoenzymes, containing different B 
subunits, have been involved in mitotic control [1]. It is 
well established that activity of PP2A-B55 is needed at the 
end of mitosis for crucial dephosphorylations required for 
correct execution of late mitotic events like cytokinesis, 
nuclear envelope reformation, etc., while the phosphatase 
is actively inhibited during mitosis onset through a recently 
identified pathway [3, 4]. During mitosis onset, Greatwall 
kinase (Gwl), another important mitotic kinase activated by 
Cdk1, phosphorylated two closely related proteins, Arpp19 
and Ensa, transforming them into potent interactors and 
inhibitors of PP2A-B55 [4]. Upon Cdk1 inactivation at the 
end of mitosis, Gwl activity downregulation allowed PP2A 
to dephosphorylate Arpp19 and Ensa and to autoactivate 
[4, 5, 6]. An important PP2A-B55 substrate is the Protein 
Required for Cytokinesis (PRC) 1, that is dephosphorylated 
at the end of mitosis at threonine 481 (pT481-PRC1), 
among several other Cdk1 substrates that are recognized 
by a commercially available anti phosphorylated Cdk1-
substrate (Cdk1 p-sub) [7]. PP2A-B56, instead, has been 
involved in the mechanisms of spindle assembly and SAC 
signaling [8]. Indeed, PP2A-B56 has been found to form 
complex with the SAC protein BubR1 and to localize at 
kinetochores, proteinaceous centrosomal structures deputed 
to interact with spindle microtubules [8–12]. Moreover, 
siRNAs-mediated downregulation of B56 and other 
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ABSTRACT
Progression through mitosis, the cell cycle phase deputed to segregate 
replicated chromosomes, is granted by a protein phosphorylation wave that follows 
an activation-inactivation cycle of cyclin B-dependent kinase (Cdk) 1, the major 
mitosis-promoting enzyme. To ensure correct chromosome segregation, the safeguard 
mechanism spindle assembly checkpoint (SAC) delays Cdk1 inactivation by preventing 
cyclin B degradation until mitotic spindle assembly. At the end of mitosis, reversal of 
bulk mitotic protein phosphorylation, downstream Cdk1 inactivation, is required to 
complete mitosis and crucially relies on the activity of major protein phosphatases 
like PP2A. A role for PP2A, however, has also been suggested in spindle assembly 
and SAC-dependent control of Cdk1. Indeed, PP2A was found in complex with SAC 
proteins while small interfering RNAs (siRNAs)-mediated downregulation of PP2A 
holoenzyme components affected mitosis completion in mammalian cells. However, 
whether the SAC-dependent control of Cdk1 required the catalytic activity of PP2A 
has never been directly assessed. Here, using two PP2A inhibitors, okadaic acid and 
LB-100, we provide evidence that PP2A activity is dispensable for SAC control of Cdk1 
in human cells. 
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PP2A holoenzyme components have been shown to delay 
spindle assembly, SAC silencing and Cdk1 inactivation 
[3, 12]. Recently, by using phosphatase inhibitors that 
target also PP2A, evidence has been provided for a role 
for protein phosphatases in SAC maintenance [13]. These 
observations have led to infer that PP2A-B56 activity 
might affect the SAC-dependent control of Cdk1, however, 
no direct evidence has been provided for this requirement. 
In addition, early dephosphorylation of a Cdk1-dependent 
phosphorylation substrate biosensor appeared not to be 
affected by the phosphatase inhibitor okadaic acid (OA) at 
doses that inhibited PP2A activity [14]. Thus, we set out 
to ask whether activity of PP2A was directly required for 
the SAC-dependent control of Cdk1 in human cells and 
gathered evidence suggesting that it is dispensable for this 
control, thus, PP2A may contribute to spindle assembly and 
SAC control by structural, rather than catalytic, means. 
RESULTS 
To study the possible effects of PP2A catalytic 
activity inhibition on SAC-dependent control of Cdk1, 
we set out to determine the effects of LB-100, a rather 
selective PP2A competitive inhibitor on maintenance and 
resolution of SAC-dependent mitotic arrest in HeLa cells 
[15]. Cells were first arrested at prometaphase by a double 
thymidine block followed by release into fresh medium 
containing nocodazole, a reversible tubulin polymerization 
inhibitor, for 12 hours. Detached mitotic HeLa cells were 
harvested, released from prometaphase arrest into fresh 
medium and immediately divided into two sets, one 
received vehicle (dimethyl sulfoxide; DMSO) as control 
and the other LB-100 (10 µM). Cells were then taken at 
the indicated time points of further incubation (Figure 1). 
Two cell samples of the control set were also treated again 
with nocodazole (Control; Noco+) to keep SAC active, 
or nocodazole plus LB-100 (Control; Noco+ LB-100+) 
to keep SAC active and inhibit PP2A, respectively, from 
time 0 of the experiment and then taken at the indicated 
time points of further incubation (Figure 1A). Cell 
lysates were probed for cyclin B1 (Cyc B1) and Cdk1 to 
monitor Cdk1 inactivation kinetics during mitosis exit; 
for phosphorylated Cdk1 substrates (Cdk1 p-subs; with an 
anti phosphospecific antibody recognizing the sequence 
P-X-pS-P and pS-P-X-K/R; where X = any residue and 
pS = phosphorylated Ser), PRC1 and phosphorylated 
PRC1 T481 (pT481-PRC1) to assess PP2A inhibition. 
Indeed, both Cdk1 p-subs and pT481-PRC1 signals 
have been shown to be lost during mitosis exit in PP2A-
dependent manner [3, 7]. In control cells, Cdk1 p-subs and 
pT481-PRC1 dephosphorylation ensued following cyclin 
B1 degradation as SAC was silenced (Figure 1A, 1B). 
In cells released into LB-100-containing medium, cyclin 
B1 was degraded with similar kinetics to control cells, 
however, dephosphorylation of Cdk1 p-subs and pT481-
PRC1 were substantially hampered for the duration of 
the experiment (Figure 1A, 1B). Indeed, quantization of 
pT481-PRC1 signal intensity showed a drop of more than 
80% during 80 min incubation from nocodazole release 
in control cells, while the signal remained substantially 
stable in the same temporal range in cells released in the 
presence of LB-100 (Figure 1B). Quantization of the 
cyclin B1 signal intensity confirmed that the protein was 
degraded with similar kinetics in control and LB-100 
treated cells (Figure 1B). In control cells treated with 
nocodazole or nocodazole plus LB-100 from time 0 
(Control; Noco+; Noco+ LB-100+), phosphorylated 
protein levels and cyclin B1 abundance remained stable 
after 100 min incubation, indicating that LB-100 did not 
induce SAC override and suggesting that PP2A activity is 
not required for SAC maintenance (Figure 1A). Together 
these data indicated that treatment of HeLa cells with the 
PP2A inhibitor LB-100 substantially inhibited PP2A-
dependent dephosphorylations observed during mitosis 
exit but did not affect cyclin B1 degradation, suggesting 
that PP2A activity is dispensable for the resolution of 
SAC-dependent inhibition of Cdk1 inactivation. In 
addition, LB-100 treatment of HeLa cells under SAC 
conditions did not override the block to cyclin B1 
degradation, suggesting that PP2A is also dispensable for 
maintenance of SAC-dependent mitotic arrest. 
We next asked whether the lack of effects of LB-
100 on SAC control observed in HeLa cells was also 
replicable in non-transformed cells. To this end, we used 
non-transformed, telomerase-immortalized, human retinal 
epithelium cells hTERT-RPE1. hTERT-RPE1 cells were 
prometaphase arrested with nocodazole following a similar 
protocol to that used for HeLa cells. Upon nocodazole 
wash out, cells were further incubated for 90 min in: fresh 
medium plus nocodazole (Noco+), just fresh medium 
(Noco−), fresh medium plus LB-100 (Noco− LB-100+), 
or fresh medium plus nocodazole and LB-100 (Noco+ LB-
100+). Total samples were separated on SDS/PAGE and 
immunoblotted for Cdk1 p-subs, pT481-PRC1, PRC1, Cyc 
B1, Cdk1, PP1 catalytic subunit phosphorylated at threonine 
320 (pT320-PP1cα) and PP1 catalytic subunit a (PP1cα) 
(Figure 1C). Release of hTERT-RPE1 cells from nocodazole 
arrest resulted in cyclin B1 degradation and Cdk1 p-subs 
and pT481-PRC1 dephosphorylations after further 90 min 
incubation in fresh medium (Noco−), while release of these 
cells into LB-100-containing medium blocked Cdk1 p-subs 
and pT481-PRC1 dephosphorylation without affecting 
cyclin B1 degradation (Noco− and Noco− LB-100+; 
Figure 1C), much like what observed in HeLa cells under 
similar conditions (Figure 1A). In addition, LB-100 did not 
induce cyclin B1 degradation in the presence of nocodazole 
(Noco+ LB-100+), indicating that PP2A inhibition did not 
cause override of the SAC-dependent arrest (Figure 1C). 
To determine whether LB-100 was affecting PP1 activity, 
we analyzed the dephosphorylation of PP1cα at threonine 
320 (pT320-PP1cα), a Cdk1-dependent inhibitory site 
that PP1 autodephosphorylates upon Cdk1 inactivation, 
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and found that it was dephosphorylated as in control cells 
indicating that LB-100 did not inhibit PP1 catalytic activity 
(Figure 1C; the lack of effect of LB-100 on pT320-PP1cα 
dephosphorylation at mitosis exit was also confirmed in 
HeLa cells, Figure 1D). Thus, also in non-transformed 
hTERT-RPE1 cells, LB-100 strongly inhibited PP2A-
dependent dephosphorylation without affecting cyclin B1 
degradation upon SAC inactivation and appeared as well 
unable to override the SAC-dependent block to cyclin B1 
degradation (Figure 1C). 
OA is a potent PP2A inhibitor that can also inhibit 
other phosphatases, including PP1, when added to cells in 
culture in a relatively high (1 µM and above) concentration 
range [16]. Indeed, in a recent report it has been shown that 
HeLa cells treated with 1 µM OA were unable to maintain 
the SAC-dependent block to cyclin B1 degradation, 
indicating that protein phosphatases were involved in SAC 
control [13]. However, our data using the LB-100 inhibitor 
indicated that PP2A activity is irrelevant for SAC-
dependent control of cyclin B1 degradation and Cdk1 
inactivation (Figure 1). To determine whether we could 
achieve rather selective inhibition of PP2A activity with 
OA and analyzed if and how this affected SAC inactivation 
or maintenance, we treated both HeLa (Figure 2A) 
and hTERT-RPE1 (Figure 2B) cells with two doses of 
OA under the following conditions. Nocodazole-treated, 
prometaphase-arrested, HeLa and hTERT-RPE1 cells were 
washed out of nocodazole and further incubated for 90 min 
in: fresh medium plus nocodazole (Noco+ OA−), just fresh 
medium (Noco− OA−), fresh medium plus OA at 0.5 µM 
(Noco− OA 0.5), fresh medium plus OA at 1 µM (Noco− 
OA 1), fresh medium plus nocodazole and OA at 0.5 µM 
(Noco+ OA 0.5) and fresh medium plus nocodazole and 
OA at 1 µM (Noco+ OA 1). Total samples were separated 
on SDS/PAGE and immunoblotted for Cdk1 p-subs, 
pT481-PRC1, PRC1, Cyc B1 and Cdk1 (Figures 2A, B). 
In both cell lines released from nocodazole and at both 
concentrations, OA substantially blocked Cdk1 p-subs and 
pT481-PRC1 dephosphorylation without affecting cyclin 
B1 degradation (compare Noco− OA− with Noco− OA 
0.5 and Noco− OA 1; Figure 2A, 2B). However, cyclin 
B1 remained stable in the presence of Noco+ OA 0.5, 
but was destabilized in the presence of Noco+ OA 1 
(Figure 2A, 2B). Thus, our data confirmed that high OA 
doses, presumably inhibiting PP1 and other phosphatases, 
induced cyclin B1 degradation by overriding the SAC-
dependent block to cyclin degradation (Noco+ OA 1; 
Figure 2A, 2B), as recently proposed [13]. Nevertheless, 
our data showed that lower concentrations of OA (0.5 µM) 
substantially blocked PP2A-dependent dephosphorylations 
but did not affect cyclin B1 degradation upon SAC 
resolution nor induced cyclin B1 degradation during 
SAC-dependent arrest (Noco− OA 0.5 and Noco+ OA 
0.5; Figure 2A, 2B). At 0.5 µM, OA did not affect cyclin 
B1 degradation kinetics even when HeLa or hTERT-
RPE1 cells were analyzed at short intervals following 
release from prometaphase arrest (Figure 2C, 2D). 
Thus, OA at concentrations that inhibit activity of PP2A 
is unable to override SAC-dependent arrest and does 
not affect the resolution of SAC-dependent inhibition of 
cyclin B degradation, further supporting the conclusion 
that PP2A activity is dispensable for the SAC-dependent 
control of Cdk1.
The progress beyond anaphase upon release from 
prometaphase arrest of HeLa and hTERT-RPE1 did not 
show substantial kinetic difference when analyzed in 
cells released into vehicle-containing fresh medium, as 
control, or into fresh medium containing OA (0.5 µM) or 
LB-100, indicating that resolution of the SAC-dependent 
block to anaphase onset was independent of PP2A activity 
(Figure 3A, 3B). At later time points from release, an 
increased number of binucleated cells could be detected 
in both cell types treated with phosphatase inhibitors (not 
shown), indicative of a requirement for PP2A activity in 
cytokinesis as previously suggested [3, 4, 7].
At the end of mitosis, Cdk1 inactivation and anaphase 
onset are determined by activation of the ubiquitin ligase 
Anaphase-Promoting Complex/Cyclosome (APC/C) 
that promotes cyclin and securin, an anaphase inhibitor, 
proteolysis in association with its coactivator Cdc20. The 
SAC delays anaphase onset and Cdk1 inactivation until 
mitotic spindle assembly by stimulating formation of a 
mitotic checkpoint complex (MCC) in which Mad2 and 
BubR1, two major SAC effector proteins, bind Cdc20 
and restrain APC/CCdc20 activation. We, thus, set out to 
determine whether PP2A activity affected MCC during 
SAC control by coimmunoprecipitation (coIp) experiments. 
Nocodazole-treated, prometaphase-arrested, HeLa cells 
were washed out of nocodazole and further incubated 
for 60 min in: fresh medium plus nocodazole (Noco+), 
just fresh medium (Noco−), fresh medium plus LB-
100 (Noco− LB-100+), fresh medium plus OA (0.5 µM; 
Noco− OA+), fresh medium plus nocodazole and LB-100 
(Noco+ LB-100+) and fresh medium plus nocodazole and 
OA (0.5 µM; Noco+ OA+; Figure 4). Cdc20 coIps from 
cell lysates were probed for BubR1, Cdc20 and Mad2 
(Figure 4A). Total lysates were also probed for BubR1, 
Cdc20 and Mad2 (Figure 4B). While in SAC-arrested cells 
(Noco+) significant amounts of Mad2 and BubR1 were 
found bound to Cdc20, marking an assembled MCC, in 
cells released from nocodazole   (Noco−), thus allowed to 
assemble spindles and inactivate SAC, Mad2 and BubR1 
substantially dissociated from Cdc20, marking MCC 
disassembly, regardless of the presence of LB-100 or OA 
(Noco− LB-100+ and Noco− OA+; Figure 4A). These 
data indicate that PP2A activity has no direct role in SAC 
resolution and MCC disassembly. In addition, PP2A does 
not appear required for SAC-dependent Cdk1 stabilization 
since the MCC remained stable and no SAC override 
was observed when PP2A was inhibited in the presence 
of nocodazole (compare Noco+ with Noco+ LB-100+ or 
Noco+ OA+; Figure 4A). These data are also in agreement 
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Figure 1: Effects of the PP2A inhibitor LB-100 on SAC maintenance and resolution in HeLa and hTERT-RPE1 cells. 
Nocodazole-treated, prometaphase-arrested, HeLa cells were collected. Upon nocodazole wash out, cells were divided into two sets, one 
received vehicle (DMSO) as control and the other LB-100 (10 µM). Cells were then taken at the indicated time points of further incubation. 
Two cell samples in the control set also received again nocodazole (Noco) and one of them LB-100 (LB-100) and, then, were taken at the 
indicated time points of further incubation. (A) Total samples were separated on SDS/PAGE and immunoblotted for phosphorylated Cdk1 
substrates (Cdk1 p-subs), pT481-PRC1, PRC1, cyclin B1 (Cyc B1) and Cdk1. (B) Optical pT481-PRC1 (triangles) and cyclin B1 (squares) 
signal density (arbitrary units; normalized for total PRC1 and Cdk1 optical density values, respectively) were plotted as percent of time 0 
samples from control (open symbols) and LB-100-treated (filled symbols) cells. (C) Nocodazole-treated, prometaphase-arrested, hTERT-
RPE1 cells were collected. Upon nocodazole wash out, cells were further incubated for 90 min in: fresh medium plus nocodazole (Noco+), 
just fresh medium    (Noco−), fresh medium plus LB-100 (Noco– LB-100+) or fresh medium plus nocodazole and LB-100 (Noco+ LB-
100+). Total samples were separated on SDS/PAGE and immunoblotted for the indicated antigens. OD, optical density values of above 
signals (arbitrary units). (D) Nocodazole-treated, prometaphase-arrested, HeLa cells were collected. Upon nocodazole wash out, cells were 
further incubated for 90 min in: fresh medium plus nocodazole (Noco+), just fresh medium    (Noco−), fresh medium plus 10 µM LB-100 
(Noco– LB-100+). Total samples were separated on SDS/PAGE and immunoblotted for the indicated antigens. OD, optical density values 
of above signals (arbitrary units). The data shown are representative of four independent experiments performed under identical conditions 
and giving similar results.
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with recently published observations indicating that the 
MCC amount and stability were not significantly affected 
in PP2A-B56-depleted cells, although the phosphorylation 
status of BubR1, analysed by migration shift on SDS/
PAGE, was indeed affected by PP2A-B56 depletion [17]. 
Thus, we analysed the migration pattern of BubR1 from 
HeLa cells exiting mitosis in the absence or presence of 
LB-100 or OA by long, higher resolving, SDS/PAGE runs 
(Figure 4C). HeLa cells were washed out of nocodazole 
and further incubated for 60 min in: fresh medium (LB-
100- OA−), fresh medium plus LB-100 (LB-100+ OA−) or 
fresh medium plus OA (0.5 µM; LB-100- OA+; Figure 4C). 
Indeed, BubR1 from cells released into fresh medium 
resolved into faster migrating forms compared to mitotic 
cells at time 0, indicative of dephosphorylation, while 
BubR1 from cells released into LB-100- or OA−containing 
medium resolved in slow migrating forms, similar to that 
from mitotic time 0 cells, and even slower migrating forms 
indicative of hyperphosphorylation (Figure 4C). Despite 
lack of BubR1 dephosphorylation, cyclin B1 degradation 
proceeded similarly in all samples (Figure 4C). These 
data suggest that also PP2A-B56 activity in particular is 
efficiently inhibited under our conditions but this does not 
affect Cdk1 inactivation.
We asked whether PP2A activity was required for 
MCC formation and implementation of the SAC effector 
branch [18, 19]. To this end, we synchronized HeLa cells 
in G2 by a 18-hour treatment with the Cdk1 inhibitor 
RO3306. From RO3306-dependent G2 arrest, cells were 
released into fresh medium and sampled at various time 
points of further incubation or released into nocodazole-
containing medium in the absence (Noco+ LB-100– OA−) 
or presence of LB-100 (10 µM, Noco+ LB-100+) or OA at 
0.5 µM (Noco+ OA+) and sampled after further 90 min of 
incubation (Figure 5). Cdc20 coIps from cell lysates were 
probed for BubR1, Cdc20 and Mad2 (Figure 5A). Total 
lysates were also probed for Cdk1 p-subs, BubR1, Cdc20, 
Cyc B1, Cdk1 and Mad2 (Figure 5B). In cells released 
Figure 2: SAC maintenance and resolution in HeLa and hTERT-RPE1 cells treated with the phosphatase inhibitor 
Okadaic Acid. Nocodazole-treated, prometaphase-arrested, (A) HeLa and (B) hTERT-RPE1 cells were collected. Upon nocodazole wash 
out cells were further incubated for 90 min in: fresh medium plus nocodazole (Noco+), just fresh medium (Noco−), fresh medium plus OA 
at 0.5 µM (Noco− OA 0.5), fresh medium plus OA at 1 µM (Noco− OA 1), fresh medium plus nocodazole and OA at 0.5 µM (Noco+ OA 
0.5) and fresh medium plus nocodazole and OA at 1 µM (Noco+ OA 1). Nocodazole-treated, prometaphase-arrested (C) HeLa and (D) 
hTERT-RPE1 cells were collected. Upon nocodazole wash out, cells were divided into two sets, one received vehicle as control (Control) 
and the other OA at 0.5 µM (OA 0.5). Cells were then taken at the indicated time points of further incubation. Total samples were separated 
on SDS/PAGE and immunoblotted for the indicated antigens. OD, optical density values of above signals (arbitrary units). The data shown 
are representative of four independent experiments per type performed under identical conditions and giving similar results. 
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just into fresh medium, BubR1 and Mad2 transiently 
bound to Cdc20, MCC reached a maximum by 30 min 
while they completely dissociated by 90 min of incubation 
(Figure 5A). In cells released into nocodazole-containing 
medium, instead, MCC was stabilized by 90 min of 
incubation as high amounts of BubR1 and Mad2 were still 
associated with Cdc20 (Figure 5A) and the cells remained 
in mitosis as indicated by high Cdk1 p-subs and cyclin B1 
signals (Figure 5B), as a consequence of an activated SAC. 
Importantly, nocodazole-dependent MCC stabilization and 
mitotic arrest were not affected by the presence of either 
LB-100 or OA, indicating that PP2A was dispensable also 
for the implementation of a functional SAC.
Together our findings indicate that PP2A activity is 
neither absolutely required for MCC formation and SAC 
activation and maintenance nor for MCC disassembly and 
SAC silencing.
DISCUSSION
The SAC is a safeguard mechanism evolved to 
ensure accurate chromosome segregation; this occurs 
by inhibiting the APC/C until all the chromosomes 
reach bipolar attachment to spindle microtubules [20]. 
Spindle assembly and SAC control rely on protein 
phosphorylation and several kinases have been involved 
in these mechanisms [8, 20]. On the other hand, protein 
phosphatases play essential roles in homeostatically 
regulating these processes [8, 19, 20, 21, 22]. In original 
works in yeast, PP1 activity was described to have a 
crucial role in silencing the SAC upon spindle assembly 
[23, 24]. PP2A-B55 activity has been shown to be required 
for mitosis completion downstream Cdk1 inactivation 
and to be necessary to control late mitotic events like 
cytokinesis and reformation of the interphase nucleus 
[4, 5, 6, 7]. PP2A-B56, instead, has been involved in 
chromosome alignment at metaphase and SAC control. 
Indeed, the SAC effector protein BubR1 has been shown 
to physically interact with the B56 subunit while small 
interfering RNAs-mediated B56 downregulation has been 
shown to affect chromosome alignment and segregation, 
leading to the hypothesis that PP2A-B56 activity was 
required to antagonize Mps1 and Aurora B kinases, 
promote stable kinetochore-microtubule interactions and 
silence the SAC [9, 10, 11]. However, other observations 
suggested that PP2A-B56 was required for chromosome 
congression at the metaphase plate, rather than to stabilize 
kinetochore-microtubule interactions by antagonizing 
Figure 3: PP2A activity does not substantially affect progression beyond anaphase. Nocodazole-treated, prometaphase-
arrested, (A) HeLa and (B) hTERT-RPE1 cells were collected. Upon nocodazole wash out, cells were divided into three sets that received 
either vehicle as control (CTRL), OA at 0.5 µM (OA), or LB-100. Cells were then taken at the indicated time points of further incubation 
and spun onto microscopy slides and processed for immunofluorescence staining for α-tubulin and the centromere marker CREST, DNA 
was stained with Hoechst. Upper graphs: post-anaphase cells were visually scored through microscopy. Error bars refer to variation within 
three independent experiments performed under identical conditions. Lower photographs: indicative images of HeLa and hTERT-RPE1 
cells taken at 60 or 40 min, respectively, of incubation. Scale bars, 10 μm.
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Aurora B action on kinetochore proteins [25].  Yet another 
study indicated that PP2A-B56 could be required to 
recruit PP1 at kinetochores, and that the activity of PP1 
would ultimately be required to silence the SAC [12]. 
Nevertheless, despite all these studies, a direct role for 
PP2A phosphatase activity in SAC regulation has been 
inferred but never directly demonstrated [25, 26]. In 
addition, OA did not prevent early dephosphorylation of a 
Cdk1-dependent phosphorylation biosensor during mitosis 
exit at doses that inhibited PP2A activity [14]. 
In this work we asked whether PP2A catalytic 
activity was directly involved in SAC and MCC-dependent 
control of Cdk1. To this end, we achieved significant 
PP2A inhibition by using the chemical inhibitors LB-100 
and OA at doses that selectively inhibited PP2A activity. 
In cells released from a SAC-dependent mitotic arrest, 
these inhibitors substantially inhibited PP2A-dependent 
dephosphorylations that mark mitosis exit but did not 
block silencing of the SAC effects on Cdk1 stabilization as 
demonstrated by the fact that disassembly of the MCC and 
cyclin B1 degradation were unaffected by these inhibitors 
(Figures 1, 2, 3 and 4). In addition, cells mounted and 
maintained a rather consistent SAC-dependent mitotic 
arrest when incubated in the presence of either PP2A 
inhibitor plus nocodazole (Figure 5). Thus, we concluded 
that the catalytic activity of PP2A is dispensable for 
Figure 4: PP2A activity does not affect MCC maintenance and disassembly. Nocodazole-treated, prometaphase-arrested, 
HeLa cells were washed out of nocodazole and further incubated for 60 min in: fresh medium plus nocodazole (Noco+), just fresh 
medium (Noco−), fresh medium plus LB-100 (10 µM; Noco− LB-100+), fresh medium plus OA (0.5 µM; Noco− OA+), fresh medium 
plus nocodazole and LB-100 (10 µM; Noco+ LB-100+) and fresh medium plus nocodazole and OA (0.5 µM; Noco+ OA+). Cdc20 
was immunoprecipitated (Ip) from cell lysates. (A) Cdc20 Ips (Cdc20 Ip) were resolved on SDS/PAGE and subsequently probed by 
immunoblotting for the indicated antigens (a total cell lysate, Tot; and mock Ip, Mk Ip, were also included as control in the SDS/PAGE; 
the asterisk marks immunoglobulin signal, *Ig). (B) Total lysates were also probed for the indicated antigens. (C) Nocodazole-treated, 
prometaphase-arrested, HeLa cells were washed out of nocodazole and further incubated for 60 min in: fresh medium (LB-100- OA−), 
fresh medium plus LB-100 (10 µM; LB-100+ OA−) or fresh medium plus OA (0.5 µM; LB-100- OA+). BubR1 was probed on blots of 
long, higher resolving, SDS/PAGE runs of total lysates (short and long blot exposures are shown). Total lysates were also probed for the 
other indicated antigens. The data shown are representative of three independent experiments performed under identical conditions and 
giving similar results.
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activation, maintenance and silencing of the SAC-
dependent control of Cdk1. Together with the previous 
observations obtained through genetic downregulation 
of PP2A subunits, our data suggest a possible role for 
PP2A in SAC control independently of its catalytic 
activity. In this perspective the PP2A holoenzyme, likely 
with B56 as B subunit, could be envisaged as the basis 
of multiprotein hubs required to control chromosome 
movements or to physically link specific structures, like 
kinetochores, to signaling molecules, like SAC proteins, 
for spindle assembly and SAC control in a catalytic 
activity-independent fashion. Alternatively, the potential 
requirement for PP2A-B56 catalytic activity in spindle 
assembly does not affect the control of MCC assembly-
disassembly and SAC-dependent control of Cdk1. 
Finally, while PP2A inhibition may help cancer therapy 
in combination with DNA damaging therapeutics by 
promoting aberrant progression into mitosis, our results 
cast doubt on the possibility that targeting PP2A activity 
may help to improve efficacy of widely used anticancer 
drugs that target the mitotic spindle like taxanes and vinca 
alkaloids by affecting the SAC-dependent mitotic delay 
[27, 28]. 
MATERIALS AND METHODS
Cell cultures and treatments
HeLa cells were grown in Dulbecco’s Modified 
Eagle’s Medium (DMEM; Sigma-Aldrich, St. Louis, MO, 
USA), hTERT-RPE1 cells were grown in Dulbecco’s 
Modified Eagle’s Medium/Nutrient Mixture F-12 
(DMEM/F12; Thermo Fischer Scientific, Waltham, 
MA, USA), both supplemented with 10% fetal bovine 
serum (FBS; GE Healthcare Hyclone, Little Chalfont, 
Buckinghamshire, UK) and penicillin–streptomycin 
(Sigma-Aldrich, St. Louis, MO, USA) as described [29]. 
Prometaphase-arrested cells were obtained by a double 
Figure 5: PP2A activity does not affect MCC formation and implementation of SAC-dependent mitotic arrest. HeLa 
cells were treated for 18 hours with RO3306 (10 µM). Upon RO3306 wash out, cells were released into: fresh medium (Noco− OA− LB-
100-), fresh medium plus nocodazole (Noco+ OA− LB-100-), fresh medium plus nocodazole and LB-100 (Noco+ OA− LB-100+) and 
fresh medium plus nocodazole and OA (Noco+ OA+ LB-100-). Cell samples were taken at the indicated time points of further incubation 
and (A) Cdc20 Ips (Cdc20 Ip) were resolved on SDS/PAGE and subsequently probed by immunoblotting for the indicated antigens (a total 
cell lysate, Tot; and mock Ip, Mk Ip, were also included as control in the SDS/PAGE; the asterisk marks immunoglobulin signal, *Ig). (B) 
Total lysates were also probed for the indicated antigens. The data shown are representative of four independent experiments performed 
under identical conditions and giving similar results.
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thymidine (4 mM; Sigma-Aldrich, St. Louis, MO, USA) 
block (18 hours each, separated by a 6 hours incubation 
in fresh medium) followed by release into fresh medium 
containing nocodazole (500 nM; Calbiochem, Billerica, 
MA, USA). Cells were further incubated for 12 or 14 
hours for HeLa and hTERT-RPE1, respectively. Then, 
cells that detached from substrate were collected and 
released from prometaphase-arrest by two washes with 
phosphate-buffer saline (PBS; EuroClone, Milan, IT) 
followed by two washes with fresh medium and final 
incubation in fresh medium. G2-arrested HeLa cells were 
obtained by one thymidine block followed by release into 
fresh medium containing RO3306 (10 μM; Calbiochem, 
Billerica, MA, USA) for 17 hours. Cells were released 
from the G2-arrest by two washes with PBS followed by 
two washes with fresh medium and final incubation in 
fresh medium. Cells released from either prometaphase- 
or G2-arrest, were collected at indicated time points of 
further incubation and lysed in NP-40/EB lysis buffer 
(0.2% NP-40; 80 mM 2-glycerophosphate, 10 mM MgCl2 
and 20 mM EGTA; Sigma-Aldrich, St. Louis, MO, USA). 
Lysates were incubated 30 minutes on ice and spun for 
20 minutes at 13.200 rpm, in a refrigerated centrifuge. 
Synchronized cells were treated with okadaic acid 
(Calbiochem, Billerica, MA, USA) at the indicated final 
concentrations or LB-100 (Selleckchem, Houston, TX, 
USA) at 10 µM.
Antibodies and immunological techniques
Primary antibodies used for immunoblots 
detection: rabbit polyclonal anti-cyclin B1 (1:1000), 
mouse monoclonal anti-CDC2 (Cdk1; 1:1000), rabbit 
polyclonal anti-PRC1 (1:250), mouse monoclonal 
anti-p-T481-PRC1 (1:300), mouse monoclonal anti-
Mad2 (1:300), rabbit polyclonal anti-P55 CDC (Cdc20; 
1:500), goat polyclonal anti-PP1α (1:200), antibodies 
were purchased from Santa Cruz Biotechnology (Dallas, 
TX, USA). Rabbit monoclonal anti-phospho-serine 
Cdk1 substrates (Cdk1 p-subs; recognizing PXpSP and 
pSPXK/R; 1:1000) and rabbit polyclonal anti phospho-
pT320-PP1α (1:750) antibodies were purchased from 
Cell Signaling Technology (Danvers, MA, USA) while 
mouse monoclonal anti-BubR1 (1:1000) antibody was 
purchased from BD Biosciences (San Jose, CA, USA). 
Secondary antibodies were peroxidase-conjugated donkey 
anti-rabbit (1:5000), anti-mouse (1:3000) or anti-goat 
(1:5000) IgG (GE Healthcare, Milan, IT) and signals were 
detected using an enhanced chemiluminescence kit (ECL; 
Cyanagen, Bologna, IT). Immunoblot signal intensity was 
measured by using ImageJ software (National Institutes of 
Health, Bethesda, MD, USA). For immunoprecipitation 
(Ips) experiments, cell lysates were incubated 30 minutes 
on ice and spun 3× for 20 minutes at 13.200 rpm, in a 
refrigerated microfuge. Cdc20 Ips were performed 
using agarose-conjugated anti p55 mouse monoclonal 
IgG (Santa Cruz Biotechnology, Dallas, TX, USA). Ips 
were incubated on a rotator wheel over night at 4°C and 
washed three times with NP-40/EB. Total lysate samples 
and Ips were separated on SDS/PAGE and blotted onto 
nitrocellulose membrane (Amersham-GE Healthcare, 
Milan, IT). For indirect immuno-fluorescence, cells were 
spun on microscopy slides, washed in PBS, fixed with 
3.7% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, 
USA) in PBS for 10 minutes at room temperature and 
permeabilized with 0.25% Triton X-100 (Sigma-Aldrich, 
St. Louis, MO, USA) in PBS for further 10 minutes. After 
blocking with 3% BSA (Sigma-Aldrich, St. Louis, MO, 
USA) in PBS for 1 hour, samples were incubated for 
3 hours with mouse anti α-tubulin (1:500; Sigma-Aldrich, 
St. Louis, MO, USA) and human anti CREST (1:100; 
Fitzgerald Industries International, North Acton, MA, 
USA) primary antibodies, both in PBS + 1% BSA. After 
3 PBS washes, samples were incubated with secondary 
antibodies (1:300; Jackson ImmunoResearch Laboratories 
Inc., West Grove, PA, USA) in PBS + 1% BSA for 1 hour 
at room temperature. DNA was stained by incubation with 
Hoechst 33258 (10 mg/ml; Santa Cruz Biotechnology, 
Dallas, TX, USA) in PBS for 10 minutes. Samples were 
observed and scored for chromosome segregation using 
an Axiovert 200 M inverted microscope, equipped with 
the Apotome slider module with a 40× objective (Zeiss, 
Oberkochen, Germany).
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